Are Options Traders Bullish on AERI?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon
Aerie Pharmaceuticals Inc.

AERI

58.45

+0.10

+0.2%

After Hours:

58.45

0.00

0.0%

Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

Stock Price
Open: 58.45
Prev. Close: 58.35
Low/Hi: 57.90 - 59.17
52-Week: 47.05 - 74.75
Volumes
Equity: 802,108
90-Day Avg: 406,128
Option: 390
90-Day Avg: 410
Volatility
Todays Stock Vol: 23.3
20-Day (HV): 38.3
52-Week (HV): 42.5
30-Day IV: 42.0 +1.8
IV Pct Rank: 13% Subdued
Fundamental
Div. Yield:
Earnings: 6-Nov (Est.)
P/E Ratio:
Market Cap: 2.6 B
Short Int Pct: 0.0%
Pct Held By Inst.: 98.6%
Stock Info
Type: Common
Sector: Healthcare
Industry: Drug Manufacturers - Major

About AERI

Aerie is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie recently reported the successful results of its second Phase 3 registration trial in the United States named Rocket 2, where the primary efficacy endpoint was to demonstrate non-inferiority of IOP lowering for Rhopressa compared to timolol. Rocket 3, a 12-month safety-only study, is currently in progress, and Aerie has recently commenced a fourth Phase 3 trial for Rhopressa, named Rocket 4. Aerie also completed in 2014 a Phase 2b clinical trial in which Roclatan met the primary efficacy endpoint, demonstrating the statistical superiority of Roclatan to each of its components, and recently commenced the first Phase 3 registration trial for Roclatan, named Mercury 1. Aerie also recently announced research collaborations with GrayBug, Inc. and Ramot at Tel Aviv University as it further builds its pipeline for future growth.
Primary Exchange: NASDAQ
SIC Biological Products, (No Diagnostic Substances)
NAICS Pharmaceutical Preparation Manufacturing

AERI is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ITOT iShares Core S&P Total U.S. Stock Market ETF 16.1 B 1.61062E+10 3,418 3418 0.01% 0.0001 1.2 M 1217350
IWM iShares Russell 2000 ETF 47.3 B 4.72794E+10 2,002 2002 0.09% 0.0009 41.7 M 4.17337E+07
IWO iShares Russell 2000 Growth ETF 11.1 B 1.11387E+10 1,211 1211 0.17% 0.0017 19.0 M 1.90074E+07
IWV iShares Russell 3000 ETF 9.2 B 9.17944E+09 2,983 2983 0.01% 0.0001 604 K 603981
JKK iShares Morningstar Small-Cap Growth ETF 214.0 M 2.14041E+08 251 251 0.31% 0.0031 659 K 659282
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 2.0 B 2E+09 968 968 0.03% 0.000273334 549 K 549130
PTH Invesco DWA Healthcare Momentum ETF 352.2 M 3.522E+08 50 50 1.44% 0.01439 5.0 M 5026022
SBIO ALPS Medical Breakthroughs ETF 276.8 M 2.7675E+08 113 113 1.5% 0.015 4.2 M 4151250
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.4 B 1.37574E+09 1,896 1896 0.0% 4.9E-05 66 K 66227
UBIO Proshares UltraPro Nasdaq Biotechnology 35.3 M 3.52545E+07 196 196 0.06% 0.000641108 75 K 75272
URTY ProShares UltraPro Russell2000 159.0 M 1.59036E+08 2,011 2011 0.01% 0.000141219 78 K 77780
UWM ProShares Ultra Russell2000 260.7 M 2.607E+08 2,011 2011 0.03% 0.000318136 184 K 184444
XPH SPDR S&P Pharmaceuticals ETF 396.2 M 3.9616E+08 46 46 1.14% 0.0114231 4.5 M 4497180
BIB ProShares Ultra Nasdaq Biotechnology 377.2 M 3.7725E+08 202 202 0.11% 0.00112304 939 K 939493
EQWS Invesco Russell 2000 Equal Weight ETF 26.3 M 2.63E+07 1,969 1969 0.03% 0.00026 7 K 6744
FHLC Fidelity MSCI Health Care Index ETF 1.5 B 1.5E+09 349 349 0.05% 0.00046805 680 K 679570
IBB iShares Nasdaq Biotechnology Index Fund 9.4 B 9.4328E+09 191 191 0.31% 0.0031 28.9 M 2.89156E+07
IHE iShares U.S. Pharmaceutical ETF 474.6 M 4.74599E+08 43 43 1.3% 0.013 6.1 M 6072070

Wait, Before You Leave...